Rhythm Pharmaceuticals, Inc. (RYTM)
82.65
-1.97
(-2.33%)
USD |
NASDAQ |
Mar 26, 14:33
Rhythm Pharmaceuticals Cash from Investing (Quarterly) : 30.35M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Aldeyra Therapeutics, Inc. | 16.00M |
| Merck & Co., Inc. | -11.20B |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
| MannKind Corp. | -291.96M |
| EyePoint Plc | -74.67M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -25.39M |
| Cash from Financing (Quarterly) | -2.948M |
| Free Cash Flow | -156.63M |
| Free Cash Flow Per Share (Quarterly) | -0.3939 |
| Free Cash Flow to Equity (Quarterly) | -9.503M |
| Free Cash Flow to Firm (Quarterly) | -21.73M |
| Free Cash Flow Yield | -2.92% |